Item 9.01. Financial Statements and Exhibits.

(a) Financial Statements of Businesses Acquired

Zikani's audited financial statements as of and for the years ended December 31, 2020 and 2019 and the related notes, as well as Zikani's unaudited condensed financial statements as of and for the three months ended March 31, 2021 and the related notes are filed as Exhibit 99.1 and Exhibit 99.2, respectively, to this Current Report on Form 8-K/A and incorporated herein by reference.

(b) Pro Forma Financial Information

The unaudited pro forma condensed consolidated financial statements of the Company as of and for the three months ended March 31, 2021 and the related notes are attached as Exhibit 99.3 to this Current Report on Form 8-K/A and incorporated herein by reference.





(c) Exhibits:



Exhibit No.   Description

  23.1          Consent of Moody, Famiglietti & Andronico, LLP, Independent
              Registered Public Accounting Firm

  99.1          Zikani Therapeutics, Inc. audited financial statements as of and for
              the years ended December 31, 2020 and 2019

  99.2          Zikani Therapeutics, Inc. unaudited condensed financial statements
              as of and for the three months ended March 31, 2021

  99.3          Unaudited pro forma condensed consolidated financial statements of
              Eloxx Pharmaceuticals, Inc.

104           Inline XBRL for the cover page of this Current Report on Form 8-K

© Edgar Online, source Glimpses